✦ LIBER ✦

Intrathecal anti-CD20 antibody: an effective and safe treatment for leptomeningeal lymphoma

✍ Scribed by Giovanni Antonini; Maria Cristina Cox; Enrico Montefusco; Antonella Ferrari; Esmeralda Conte; Stefania Morino; Pamela Latino; Guido Trasimeni; Bruno Monarca

Book ID: 106480628
Publisher: Springer US
Year: 2006
Tongue: English
Weight: 147 KB
Volume: 81
Category: Article
ISSN: 0167-594X
DOI: 10.1007/s11060-006-9217-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of radiation-relapsing primary

Treatment of radiation-relapsing primary cutaneous B-cell lymphoma with an anti-CD20 monoclonal antibody

✍ M. E. Lacouture; J. M. Baron; A. B Jani; A. E Laumann; K Soltani 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB

Chimeric monoclonal anti-CD20 antibody (

Chimeric monoclonal anti-CD20 antibody (rituximab)—an effective treatment for a patient with relapsing hairy cell leukaemia

✍ H Hagberg 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 120 KB

Monoclonal Antibody Therapy for B-Cell L

Monoclonal Antibody Therapy for B-Cell Lymphoma: Clinical Trials of an Anti-CD20 Monoclonal Antibody for B-Cell Lymphoma in Japan

✍ Kensei Tobinai 📂 Article 📅 2002 🏛 Carden Jennings Publishing 🌐 English ⚖ 276 KB

Synergistic cytotoxicity of iodine-131-a

Synergistic cytotoxicity of iodine-131-anti-CD20 monoclonal antibodies and chemotherapy for treatment of B-cell lymphomas

✍ Timothy A. Johnson; Oliver W. Press 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 231 KB

Preliminary clinical trials suggest that iodine-131 ( 131 I)labeled anti-CD20 monoclonal antibodies (MAbs) are effective single agents for the treatment of relapsed non-Hodgkin's B-cell lymphomas. However, despite high initial response rates, most patients treated in this manner will eventually rela

The anti-CD20 antibody rituximab augment

The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma

✍ David J. Flavell; Sarah L. Warnes; Christine J. Bryson; Sarah A. Field; Armorel 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 548 KB

Successful Treatment With a Chimeric Ant

Successful Treatment With a Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab) for a Patient With Relapsed Mantle Cell Lymphoma Who Developed a Human Anti-Chimeric Antibody

✍ Takahiro Maeda; Yasuaki Yamada; Masayuki Tawara; Reishi Yamasaki; Yuichi Yakata; 📂 Article 📅 2001 🏛 Carden Jennings Publishing 🌐 English ⚖ 188 KB